lidoflazine has been researched along with phenylalanine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dooley, PC; Hancox, JC; Milnes, JT; Ridley, JM; Witchel, HJ | 1 |
1 other study(ies) available for lidoflazine and phenylalanine
| Article | Year |
|---|---|
Lidoflazine is a high affinity blocker of the HERG K(+)channel.
Topics: Cell Line; Electrophysiology; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Lidoflazine; Mutation; Phenylalanine; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Tyrosine | 2004 |